Our newest portfolio stocks pulled back from their recent 52-week high, so we're buying more
We are buying 300 shares of Bristol-Myers Squibb at approximately $58 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will…
We are buying 300 shares of Bristol-Myers Squibb at approximately $58 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will…
The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…
Customers wait in a long line at a Starbucks coffee shop in a terminal at Miami International Airport in Miami…
We are purchasing 25 shares of Danaher at approximately $229 each. Following Monday's trade, Jim Cramer's Charitable Trust will own…
Robert F. Kennedy Jr. attends a campaign event for Republican presidential candidate and former US President Donald Trump in Milwaukee,…
My Top 10 Things to Watch for Friday, Nov. 15 1. President-elect Donald Trump's decision to nominate prominent vaccine skeptic…
Enthusiasm for Eli Lilly, the club's holding company, needs to be tempered, at least for now, as Wall Street grapples…
Jakub Porzycki | Nurfoto | fake images Novo Nordisk on Wednesday reported a beat in third-quarter sales of its blockbuster…
GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue declined slightly, an improvement in earnings along with…
Shares of Abbott Laboratories rose on Friday after the Club holding company scored a surprise victory in a trial into…